The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Ecuador is now 90%, marking a 14% (18.4%) increase compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Ecuador
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Ecuador
PMTCT antiretroviral therapy coverage
More indicators for Ecuador
Male unintentional poisoning
0.4
-0.1
(2019)
Female wasting in children
3.1%
+1.7%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar297
+intl dollar8
(2021)
Birth registration
87.2%
+5.2%
(2020)
Contraceptive modern method prevalence
72.4%
+5.2%
(2019)
Ecuador PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 90% | +14% |
| 2021 | 76% | +15% |
| 2020 | 61% | -18% |
| 2019 | 79% | +28% |
| 2018 | 51% | 0% |
| 2017 | 51% | +1% |
| 2016 | 50% | +1% |
| 2015 | 49% | +2% |
| 2014 | 47% | +1% |
| 2013 | 46% | +1% |
| 2012 | 45% | +3% |
| 2011 | 42% | +3% |
| 2010 | 39% | +2% |
| 2009 | 37% | -2% |
| 2008 | 39% | +39% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |